Trials / Completed
CompletedNCT04702529
Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device
Soliton's Rapid Acoustic Pulse (RAP) Device for the Treatment of Fibrotic Scars: Multi-Treatment Proof-of-Concept Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Soliton · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars
Detailed description
Soliton's Rapid Acoustic Pulse(RAP) device is an electrohydraulic (EH) device using Soliton's Rapid Acoustic Pulse (RAP) technology developed to minimize the appearance of scars through both micro-disruption of the scar matrix leading to scar remodeling and down regulation of the 'fibrotic fibroblasts'
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device) | Administration of 3 Rapid Acoustic Pulse (RAP) treatments |
Timeline
- Start date
- 2022-06-22
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2021-01-11
- Last updated
- 2024-12-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04702529. Inclusion in this directory is not an endorsement.